UPN2357_Guth_29_S33_L002_R1_001.fastq.gz
syn25874192
Created By
Elliot Stieglitz estieglitz
age: 0
sex: Male
Uuid: 2075dbb3-cbe6-4a0a-8e7c-760bf95ef085
assay: bisulfite sequencing
organ:
tissue: blood
ageUnit: months
runType: pairedEnd
species: Homo sapiens
studyId: syn51133946
comments:
dataType: chromatin activity
entityId: syn25874192
platform: Illumina NovaSeq 6000
readPair: 1
Component: EpigeneticsAssayTemplate
aliquotID:
diagnosis:
readDepth:
studyName: DHART SPORE Project 3 - A High Content Clinical Trial (ADVL1521) of the MEK Inhibitor Trametinib in Juvenile Myelomonocytic Leukemia (JMML), a Phase II clinical trial
tumorType: Juvenile Myelomonocytic Leukemia
fileFormat: fastq
initiative: DHART-SPORE Project 3
isCellLine: No
readLength: 150
specimenID: UPN2357_Guth_29
assayTarget:
dataSubtype: raw
nf1Genotype: Unknown
nf2Genotype: Unknown
individualID: UPN2357_Guth_29
resourceType: experimentalData
fundingAgency: NIH-NCI
isPrimaryCell: Yes
timePointUnit:
parentSpecimenID: UPN2357_Guth_29
nucleicAcidSource: bulk cell
dissociationMethod:
genePerturbationType: Not Applicable
experimentalTimepoint:
specimenPreparationMethod:
genePerturbationTechnology:
Drop files to upload
Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this
AJAX application crawl link
UPN2357_Guth_29_S33_L002_R1_001.fastq.gz
page is loading…